3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
17
Carcinoma, Intraductal, Noninfiltrating
5
Breast Carcinoma In Situ
4
Neoplasms
2
Infertility
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Polycystic Ovary Syndrome
1
Pancreatic Cyst
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Breast Neoplasms, Male
1
Anovulation
1
Interventions
Bevacizumab
13
atezolizumab
9
Specimen Handling
9
durvalumab
7
Nivolumab
7
Magnetic Resonance Spectroscopy
7
lenvatinib
6
tremelimumab
5
cabozantinib
4
tislelizumab
3
donafenib
3
X-Rays
3
Surgical Procedures, Operative
3
Sorafenib
3
Oxaliplatin
3
Ipilimumab
3
Immunotherapy
3
Fluorouracil
3
ulixertinib
2
sintilimab
2
sapanisertib
2
relatlimab
2
pembrolizumab
2
camrelizumab
2
apatinib
2
Leucovorin
2
Irinotecan
2
Fluorodeoxyglucose F18
2
Carboplatin
2
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Tamoxifen
×
30 days
×
Clear all
No trials found.